Caroline Knittel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Caroline Knittel has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Neal Krishna Devaraj
University of California San Diego
3 shared publications - Andi Mainz
Institut für Chemie, Technische Universität Berlin, 10623 Berlin, Germany
2 shared publications - Arnar Sigurdsson
Fakultät II–Institut für Chemie Technische Universität Berlin Straße des 17. Juni 124 10623 Berlin Germany
2 shared publications Benjamin Dimos‐Röhl
Fakultät II–Institut für Chemie Technische Universität Berlin Straße des 17. Juni 124 10623 Berlin Germany
2 shared publications- Berta M. Martins
Institut für Biologie Humboldt‐Universität zu Berlin Berlin Germany
2 shared publications Bianca Schmid
Fakultät II–Institut für Chemie Technische Universität Berlin Straße des 17. Juni 124 10623 Berlin Germany
2 shared publications
Latest Publications
- Open Access
- 8 May 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Targeted Detection of Phospholipid Aldehydes in Living Cells by Oxime Ligation
Oxidatively damaged lipids play critical roles in numerous human pathologies, yet methods to directly identify these species within living cells remain limited due to their transient and low-abundance nature. Existing probes for imaging lipid oxidation often rely on indirect strategies, such as monitoring changes in the fluorescence intensity or color of oxidizable probes, which detect the presence of lipid peroxidation but not its direct chemical products. Among lipid oxidation products, aldehyde-containing lipids are particularly significant due to their heightened reactivity and strong links to disease pathology. Here, we introduce OxiLox, a method that leverages fluorescent hydroxylamine-based probes to enable direct, chemoselective tagging of aldehyde-containing lipids in situ within living cells via rapid oxime ligation. Using confocal microscopy, we map the subcellular localization of these oxidized lipids, highlighting prominent accumulation within perinuclear membranes, particularly under oxidative stress conditions induced by the ferroptosis activator RSL3. Coupled with high-resolution mass spectrometry, our method precisely identifies aldehyde lipid species, notably revealing the abundance of oxidized plasmenyl phosphatidylethanolamines in ferroptotic cells. We demonstrate that cellular labeling by hydroxylamine probes can be modulated by altering the expression of antioxidant enzymes such as aldose reductase (AKR1B1), underscoring the relationship between enzymatic antioxidant defenses and lipid aldehyde metabolism. Our work establishes OxiLox as a robust approach for direct, sensitive, and chemically precise detection of lipid aldehydes in live cells, offering critical new insights into the role of lipid oxidation in health and disease.
- 8 May 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessTargeted Detection of Phospholipid Aldehydes in Living Cells by Oxime Ligation
Oxidatively damaged lipids play critical roles in numerous human pathologies, yet methods to directly identify these species within living cells remain limited due to their transient and low-abundance nature. Existing probes for imaging lipid oxidation often rely on indirect strategies, such as monitoring changes in the fluorescence intensity or color of oxidizable probes, which detect the presence of lipid peroxidation but not its direct chemical products. Among lipid oxidation products, aldehyde-containing lipids are particularly significant due to their heightened reactivity and strong links to disease pathology. Here, we introduce OxiLox, a method that leverages fluorescent hydroxylamine-based probes to enable direct, chemoselective tagging of aldehyde-containing lipids in situ within living cells via rapid oxime ligation. Using confocal microscopy, we map the subcellular localization of these oxidized lipids, highlighting prominent accumulation within perinuclear membranes, particularly under oxidative stress conditions induced by the ferroptosis activator RSL3. Coupled with high-resolution mass spectrometry, our method precisely identifies aldehyde lipid species, notably revealing the abundance of oxidized plasmenyl phosphatidylethanolamines in ferroptotic cells. We demonstrate that cellular labeling by hydroxylamine probes can be modulated by altering the expression of antioxidant enzymes such as aldose reductase (AKR1B1), underscoring the relationship between enzymatic antioxidant defenses and lipid aldehyde metabolism. Our work establishes OxiLox as a robust approach for direct, sensitive, and chemically precise detection of lipid aldehydes in live cells, offering critical new insights into the role of lipid oxidation in health and disease.
- Open Access
- 12 July 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Photochemical synthesis of natural membrane lipids in artificial and living cells
A general method for the abiogenesis of natural lipids could transform the development of lifelike artificial cells and unlock new ways to explore lipid functions in living cells. However, it is unclear if mild non-enzymatic methods can be harnessed to synthesize the diverse array of lipids found in biology. Here, we demonstrate the abiotic formation of natural lipids in water using visible-light-driven photoredox chemistry. Radical-mediated coupling of hydrocarbon tails to polar single-chain precursors yields lipids identical to those enzymatically formed. Spatiotemporally controlled lipid generation promotes de novo vesicle formation, growth, and division. Several photoredox catalysts, including those activated by nucleic acids, can drive lipid synthesis. Additionally, we show that the synthesis of bioactive lipids can trigger signaling in living cells.
- 12 July 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessPhotochemical synthesis of natural membrane lipids in artificial and living cells
A general method for the abiogenesis of natural lipids could transform the development of lifelike artificial cells and unlock new ways to explore lipid functions in living cells. However, it is unclear if mild non-enzymatic methods can be harnessed to synthesize the diverse array of lipids found in biology. Here, we demonstrate the abiotic formation of natural lipids in water using visible-light-driven photoredox chemistry. Radical-mediated coupling of hydrocarbon tails to polar single-chain precursors yields lipids identical to those enzymatically formed. Spatiotemporally controlled lipid generation promotes de novo vesicle formation, growth, and division. Several photoredox catalysts, including those activated by nucleic acids, can drive lipid synthesis. Additionally, we show that the synthesis of bioactive lipids can trigger signaling in living cells.
- Open Access
- 29 January 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Enzymatic activation of caged tetrazines for cell-specific bioconjugation
Tetrazine ligation techniques have evolved into a versatile tool set for bioconjugation. Despite their numerous applications, highly reactive tetrazines can suffer from long-term instability and off-target reactivity, and achieving cell-specific bioconjugation remains challenging. Tetrazine caging techniques intend to overcome these issues by achieving spatial and temporal control over tetrazine activation from stable dihydrotetrazine derivatives. Here we explore enzyme-initiated tetrazine uncaging, allowing for controlled release of reactive tetrazines by enzymes overexpressed in specific cell types. Using a modular synthetic strategy, we connected four distinct enzyme-cleavable motifs to caged tetrazine derivatives using a self-immolative linker unit. We validated cell-specific release using penicillin G amidase (PGA), which we genetically encoded into HEK293Ts. Cells expressing PGA were able to activate tetrazines which subsequently reacted with a dienophile-protected doxorubicin, lowering viability. In contrast, treatment of mammalian cells lacking PGA showed no reduction in cell viability. Additionally, we generated enzyme-cleavable conjugates that are hydrolyzed by enzymes commonly exploited for drug delivery in human cells, including esterases, cathepsin B, and alkaline phosphatases. We demonstrate cell-type specific activation of tetrazines based on the varying expression levels of alkaline phosphatases in different cell lines. Specifically, we compared tetrazine activation in the osteosarcoma cell line SAOS-2, known for its exceptionally high ALP expression levels, to cells that express lower levels of ALP, the colorectal adenocarcinoma cell line HT-29 and the stromal cell line HS-5. Overall, we find that tetrazine release from enzyme-cleavable tetrazine derivatives is dependent on the enzyme activity present in specific cells and therefore constitutes a promising technique for cell-type specific bioconjugation.
- 29 January 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessEnzymatic activation of caged tetrazines for cell-specific bioconjugation
Tetrazine ligation techniques have evolved into a versatile tool set for bioconjugation. Despite their numerous applications, highly reactive tetrazines can suffer from long-term instability and off-target reactivity, and achieving cell-specific bioconjugation remains challenging. Tetrazine caging techniques intend to overcome these issues by achieving spatial and temporal control over tetrazine activation from stable dihydrotetrazine derivatives. Here we explore enzyme-initiated tetrazine uncaging, allowing for controlled release of reactive tetrazines by enzymes overexpressed in specific cell types. Using a modular synthetic strategy, we connected four distinct enzyme-cleavable motifs to caged tetrazine derivatives using a self-immolative linker unit. We validated cell-specific release using penicillin G amidase (PGA), which we genetically encoded into HEK293Ts. Cells expressing PGA were able to activate tetrazines which subsequently reacted with a dienophile-protected doxorubicin, lowering viability. In contrast, treatment of mammalian cells lacking PGA showed no reduction in cell viability. Additionally, we generated enzyme-cleavable conjugates that are hydrolyzed by enzymes commonly exploited for drug delivery in human cells, including esterases, cathepsin B, and alkaline phosphatases. We demonstrate cell-type specific activation of tetrazines based on the varying expression levels of alkaline phosphatases in different cell lines. Specifically, we compared tetrazine activation in the osteosarcoma cell line SAOS-2, known for its exceptionally high ALP expression levels, to cells that express lower levels of ALP, the colorectal adenocarcinoma cell line HT-29 and the stromal cell line HS-5. Overall, we find that tetrazine release from enzyme-cleavable tetrazine derivatives is dependent on the enzyme activity present in specific cells and therefore constitutes a promising technique for cell-type specific bioconjugation.
- Open Access
- 27 April 2023
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 62 (23)
Discovery of the Lanthipeptide Curvocidin and Structural Insights into its Trifunctional Synthetase CuvL
Lanthipeptides are ribosomally‐synthesized natural products from bacteria featuring stable thioether‐crosslinks and various bioactivities. Herein, we report on a new clade of tricyclic class‐IV lanthipeptides with curvocidin from Thermomonospora curvata as its first representative. We obtained crystal structures of the corresponding lanthipeptide synthetase CuvL that showed a circular arrangement of its kinase, lyase and cyclase domains, forming a central reaction chamber for the iterative substrate processing involving nine catalytic steps. The combination of experimental data and artificial intelligence‐based structural models identified the N‐terminal subdomain of the kinase domain as the primary site of substrate recruitment. The ribosomal precursor peptide of curvocidin employs an amphipathic α‐helix in its leader region as an anchor to CuvL, while its substrate core shuttles within the central reaction chamber. Our study thus reveals general principles of domain organization and substrate recruitment of class‐IV and class‐III lanthipeptide synthetases.
- 27 April 2023
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 62 (23)
Open AccessDiscovery of the Lanthipeptide Curvocidin and Structural Insights into its Trifunctional Synthetase CuvL
Lanthipeptides are ribosomally‐synthesized natural products from bacteria featuring stable thioether‐crosslinks and various bioactivities. Herein, we report on a new clade of tricyclic class‐IV lanthipeptides with curvocidin from Thermomonospora curvata as its first representative. We obtained crystal structures of the corresponding lanthipeptide synthetase CuvL that showed a circular arrangement of its kinase, lyase and cyclase domains, forming a central reaction chamber for the iterative substrate processing involving nine catalytic steps. The combination of experimental data and artificial intelligence‐based structural models identified the N‐terminal subdomain of the kinase domain as the primary site of substrate recruitment. The ribosomal precursor peptide of curvocidin employs an amphipathic α‐helix in its leader region as an anchor to CuvL, while its substrate core shuttles within the central reaction chamber. Our study thus reveals general principles of domain organization and substrate recruitment of class‐IV and class‐III lanthipeptide synthetases.
- Open Access
- 27 April 2023
- Published by Wiley in Angewandte Chemie
- Vol. 135 (23)
Discovery of the Lanthipeptide Curvocidin and Structural Insights into its Trifunctional Synthetase CuvL
Lanthipeptides are ribosomally‐synthesized natural products from bacteria featuring stable thioether‐crosslinks and various bioactivities. Herein, we report on a new clade of tricyclic class‐IV lanthipeptides with curvocidin from Thermomonospora curvata as its first representative. We obtained crystal structures of the corresponding lanthipeptide synthetase CuvL that showed a circular arrangement of its kinase, lyase and cyclase domains, forming a central reaction chamber for the iterative substrate processing involving nine catalytic steps. The combination of experimental data and artificial intelligence‐based structural models identified the N‐terminal subdomain of the kinase domain as the primary site of substrate recruitment. The ribosomal precursor peptide of curvocidin employs an amphipathic α‐helix in its leader region as an anchor to CuvL, while its substrate core shuttles within the central reaction chamber. Our study thus reveals general principles of domain organization and substrate recruitment of class‐IV and class‐III lanthipeptide synthetases.
- 27 April 2023
- Published by Wiley in Angewandte Chemie
- Vol. 135 (23)
Open AccessDiscovery of the Lanthipeptide Curvocidin and Structural Insights into its Trifunctional Synthetase CuvL
Lanthipeptides are ribosomally‐synthesized natural products from bacteria featuring stable thioether‐crosslinks and various bioactivities. Herein, we report on a new clade of tricyclic class‐IV lanthipeptides with curvocidin from Thermomonospora curvata as its first representative. We obtained crystal structures of the corresponding lanthipeptide synthetase CuvL that showed a circular arrangement of its kinase, lyase and cyclase domains, forming a central reaction chamber for the iterative substrate processing involving nine catalytic steps. The combination of experimental data and artificial intelligence‐based structural models identified the N‐terminal subdomain of the kinase domain as the primary site of substrate recruitment. The ribosomal precursor peptide of curvocidin employs an amphipathic α‐helix in its leader region as an anchor to CuvL, while its substrate core shuttles within the central reaction chamber. Our study thus reveals general principles of domain organization and substrate recruitment of class‐IV and class‐III lanthipeptide synthetases.
- Open Access
- 8 December 2022
- Published by Wiley in Analytical Science Advances
- Vol. 4 (1-2) , 4-5
The road from PhD in Germany to postdoc in the USA
- 8 December 2022
- Published by Wiley in Analytical Science Advances
- Vol. 4 (1-2) , 4-5
Open AccessThe road from PhD in Germany to postdoc in the USA